JPS52113954A - Local pharmaceutical agent containing clindamycine - Google Patents
Local pharmaceutical agent containing clindamycineInfo
- Publication number
- JPS52113954A JPS52113954A JP2936277A JP2936277A JPS52113954A JP S52113954 A JPS52113954 A JP S52113954A JP 2936277 A JP2936277 A JP 2936277A JP 2936277 A JP2936277 A JP 2936277A JP S52113954 A JPS52113954 A JP S52113954A
- Authority
- JP
- Japan
- Prior art keywords
- clindamycine
- agent containing
- pharmaceutical agent
- local pharmaceutical
- local
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/668,389 US4018918A (en) | 1975-05-20 | 1976-03-19 | Topical clindamycin preparations |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS52113954A true JPS52113954A (en) | 1977-09-24 |
Family
ID=24682131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2936277A Pending JPS52113954A (en) | 1976-03-19 | 1977-03-18 | Local pharmaceutical agent containing clindamycine |
Country Status (7)
Country | Link |
---|---|
JP (1) | JPS52113954A (hu) |
BE (1) | BE852649R (hu) |
DE (1) | DE2710880A1 (hu) |
FR (1) | FR2344288A2 (hu) |
GB (1) | GB1527061A (hu) |
NL (1) | NL7702822A (hu) |
ZA (1) | ZA77943B (hu) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04169529A (ja) * | 1990-10-30 | 1992-06-17 | Nippon Soda Co Ltd | 家蓄の乳房炎を予防する方法 |
JPH05501115A (ja) * | 1990-03-27 | 1993-03-04 | シェリング・コーポレーション | 9α―ヒドロキシ ステロイドの脱水法 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6214318B1 (en) | 1997-10-02 | 2001-04-10 | Oms Holdings Llc | Aerosol ointment compositions for topical use |
AU9588598A (en) * | 1997-10-02 | 1999-04-27 | Dorothea C. Marra | Aerosol ointment compositions and method of manufacture |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1403962A (en) * | 1972-03-09 | 1975-08-28 | Upjohn Co | Anti-inflammatory pregnane derivative |
-
1977
- 1977-02-16 ZA ZA770943A patent/ZA77943B/xx unknown
- 1977-03-10 GB GB10067/77A patent/GB1527061A/en not_active Expired
- 1977-03-12 DE DE19772710880 patent/DE2710880A1/de not_active Withdrawn
- 1977-03-16 NL NL7702822A patent/NL7702822A/xx not_active Application Discontinuation
- 1977-03-18 BE BE175931A patent/BE852649R/xx not_active IP Right Cessation
- 1977-03-18 JP JP2936277A patent/JPS52113954A/ja active Pending
- 1977-03-18 FR FR7708238A patent/FR2344288A2/fr active Granted
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05501115A (ja) * | 1990-03-27 | 1993-03-04 | シェリング・コーポレーション | 9α―ヒドロキシ ステロイドの脱水法 |
JPH04169529A (ja) * | 1990-10-30 | 1992-06-17 | Nippon Soda Co Ltd | 家蓄の乳房炎を予防する方法 |
Also Published As
Publication number | Publication date |
---|---|
NL7702822A (nl) | 1977-09-21 |
BE852649R (fr) | 1977-09-19 |
FR2344288A2 (fr) | 1977-10-14 |
GB1527061A (en) | 1978-10-04 |
ZA77943B (en) | 1977-12-28 |
DE2710880A1 (de) | 1977-09-29 |
FR2344288B2 (hu) | 1980-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS52145525A (en) | Local antiiinflammation agent | |
JPS52143218A (en) | Pharmaceutical composition | |
JPS52134027A (en) | Antiitumor agent | |
JPS52113976A (en) | Pharmaceutical composition | |
JPS5362838A (en) | Pharmaceutical composition | |
JPS52102432A (en) | Pharmaceutical composition containing pyretrinoid | |
JPS5372814A (en) | Pharmaceutical composition | |
JPS5325525A (en) | Radiooopaque agent | |
JPS5470433A (en) | Antiiulcer agent | |
JPS5299230A (en) | Antiitumor agent | |
JPS52118497A (en) | Antiiallergy agent | |
AU3152677A (en) | Pharmaceutical composition | |
JPS5369822A (en) | Pharmaceutical agent | |
JPS5297933A (en) | Antiihypertensive agent | |
AU2649977A (en) | Pharmaceutical composition | |
JPS5356634A (en) | Pharmaceutical composition | |
JPS535195A (en) | Antiibacterial agent | |
JPS5335084A (en) | Airzol size agent | |
JPS52117436A (en) | Antiicoccidium agent | |
SU725543A3 (en) | Insecticidic agent | |
JPS5386040A (en) | Antiicoagulating agent | |
JPS52113954A (en) | Local pharmaceutical agent containing clindamycine | |
JPS5335085A (en) | Airzol size agent | |
JPS5297963A (en) | Antiihypertensive agent | |
JPS52114025A (en) | Antiitumor agent |